NEWSROOM
Read expert commentary on market trends, operational strategies, and the technology shaping the future of investment management.
BOISE, Idaho, April 23, 2026 — Clearwater Analytics Holdings, Inc. (NYSE: CWAN), (“CWAN” or the “Company”), the most comprehensive technology platform for investment management, will release financial results for the first quarter ended March 31, 2026 after the U.S. financial markets close on Thursday, May 7, 2026.
Clearwater Analytics announced today that general insurer MSIG has selected Clearwater to support its transformation strategy, standardize its operating model, and provide a consolidated view of data, analytics, accounting, regulatory, and operational reporting across all of its entities.
Enfusion, a leading provider of cloud-based investment management software and services, today announced financial results for the first quarter ended March 31, 2022.
Clearwater Analytics (NYSE: CWAN), a leading provider of SaaS-based investment accounting, reporting, and analytics solutions, announced several enhancements to their product offering during Q1 2022.
Enfusion, a leading provider of cloud-native investment management software and services, to partner with Northern Trust to provide portfolio management, order and execution management system (OEMS), and analytics capabilities.
Clearwater Analytics (NYSE: CWAN), a leading provider of SaaS-based investment accounting, reporting, and analytics solutions, announced several enhancements to their product offering during Q1 2022.
“Clearwater Analytics had an extremely strong quarter, achieving significant top-line growth across all of our industry verticals, especially asset management,” said Sandeep Sahai, Chief Executive Officer.
Clearwater Analytics Holdings, Inc. (NYSE: CWAN), (“Clearwater Analytics” or the “Company”) will release financial results for the first quarter ended March 31, 2022 after the U.S. financial markets close on Wednesday, May 4, 2022.
Enfusion, Inc. announced two internal executive promotions. Iris Xinwei Wang will serve as Enfusion’s Chief Strategy Officer, based in New York. Additionally, Lotte Tønsberg will serve as the London-based Head of Sales for EMEA.
Enfusion, Inc. announced two internal executive promotions. Iris Xinwei Wang will serve as Enfusion’s Chief Strategy Officer, based in New York. Additionally, Lotte Tønsberg will serve as the London-based Head of Sales for EMEA.